Wright Medical Group (WMGI) Posts Q4 Loss of $0.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Wright Medical (WMGI) PT Raised to $31 at BMO Capital Following Strong 4Q Results
February 22, 2017 8:59 AM ESTBMO Capital Markets analyst Joanne Wuensch reiterates Outperform rating and raises price target on Wright Medical Group NV (NASDAQ: WMGI) to $31 (from 427), suggesting a positive outlook, as the company reported 2016 fourth quarter revenues and EPS above consensus, offering 2017 guidance above consensus estimates.
Wuensch... More
Jefferies Reiterates Buy on Wright Medical Group (WMGI) Following 4Q
February 22, 2017 7:14 AM ESTJefferies reiterated a Buy rating and $30.00 price target on Wright Medical Group (NASDAQ: WMGI) following the company's 4Q earnings report.
Analyst Raj Denhoy commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high... More
Needham & Company Maintains Hold Rating on Wright Medical Group (WMGI) Following Strong 4Q16 Results
February 22, 2017 6:26 AM ESTNeedham and & Company analyst Mike Matson reiterates Hold rating on Wright Medical Group NV (NASDAQ: WMGI), as the company delivered 2016 fourth quarter revenue and EBITDA above consensus, while offering 2017 revenue guidance above consensus projections.
Matson comments, "WMGI's 4Q16 revenue and EBITDA beat consensus, and... More
